FAMHP (Belgian Medicine Agency)

FAMHP launches BioVigilance web application for adverse event reporting

Original title: The new BioVigilance web application is now available

FAMHP released BioVigilance, an online application for reporting serious adverse events related to substances of human origin intended for human use.

Medium impact Digital Health & AI General Regulatory Belgium pharmacovigilancehealth-data

The FAMHP launches BioVigilance, a new online application for reporting serious adverse events and reactions related to reproductive and non-reproductive substances of human origin (SoHO) intended for human application.

Read the official source ↗

Published by FAMHP (Belgian Medicine Agency). HealthSignal links to the original document; the summary above is extracted from the source text.